SPI Pharma Inc:企業の戦略的SWOT分析

◆英語タイトル:SPI Pharma Inc - Strategic SWOT Analysis Review
◆商品コード:SWOT20MY2881
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥16,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥32,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥48,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

SPI Pharma Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

SPI Pharma Inc (SPI Pharma), a subsidiary of SPI Holdings Inc. provides pharmaceutical ingredients and technologies for patient-friendly dosage forms. The company undertakes the manufacturing and marketing of various pharmaceutical products and technologies to solve challenging formulation problems. It offers a wide range of pharmaceuticals products which contain antacid actives, soluble excipients, taste-masking technology actives, vaccine adjuvants and drug delivery systems for oral dose applications. SPI Pharma offers products in various formulations such as chewables, lozenges, powders and other patient-friendly dosage forms such as swallow tablets, chewable tablets, fast dissolve tablets and soft gelatin capsules. The company also offers contract manufacturing services to other companies. It operates business through manufacturing sites, research and development centers and sales offices located in the UK, Canada, China, France and India. SPI Pharma is headquartered in Wilmington, Delaware, the US.

SPI Pharma Inc Key Recent Developments

Mar 24,2020: SPI Pharma expands Mannogem Mannitol product portfolio to support the development, manufacture and administration of oral dosage forms.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
SPI Pharma Inc – Key Facts
SPI Pharma Inc – Key Employees
SPI Pharma Inc – Major Products and Services
SPI Pharma Inc – History
SPI Pharma Inc – Company Statement
SPI Pharma Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
SPI Pharma Inc – Business Description
SPI Pharma Inc – SWOT Analysis
SWOT Analysis – Overview
SPI Pharma Inc – Strengths
SPI Pharma Inc – Weaknesses
SPI Pharma Inc – Opportunities
SPI Pharma Inc – Threats
SPI Pharma Inc – Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
SPI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
SPI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
SPI Pharma Inc, Recent Deals Summary
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
SPI Pharma Inc, Key Facts
SPI Pharma Inc, Key Employees
SPI Pharma Inc, Major Products and Services
SPI Pharma Inc, History
SPI Pharma Inc, Other Locations
SPI Pharma Inc, Subsidiaries
SPI Pharma Inc, Key Competitors
SPI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
SPI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
SPI Pharma Inc, Recent Deals Summary

List of Figures
SPI Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
SPI Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[SPI Pharma Inc:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bombril SA (BOBR4):企業の財務・戦略的SWOT分析
    Bombril SA (BOBR4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Millennium Minerals Limited:企業の戦略・SWOT・財務分析
    Millennium Minerals Limited - Strategy, SWOT and Corporate Finance Report Summary Millennium Minerals Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Avacta Group Plc (AVCT):医療機器:M&Aディール及び事業提携情報
    Summary Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products that include optim and sensipod. It also develops UCB celltech that is an analytical instrument. Avacta’s sensipod is an …
  • Nuevolution AB (NUE):製薬・医療:M&Aディール及び事業提携情報
    Summary Nuevolution AB (Nuevolution) is a biopharmaceutical company focused on developing drug treatments for cancer and chronic inflammatory diseases. The company’s pipeline products include RORyt inhibitor, BRD (BD1), cytokine X, RORyt agonist, and GRP78. Its products are used for various indicati …
  • Hersha Hospitality Trust:企業のM&A・事業提携・投資動向
    Hersha Hospitality Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hersha Hospitality Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • RWE AG (RWE)-石油・ガス分野:企業M&A・提携分析
    Summary RWE AG (RWE) is an energy company that generates, transmits and distributes electricity. The company generates electricity using various sources such as gas, hard coal, lignite, nuclear, hydro, biomass and renewables. It also produces oil, gas and lignite; and distributes and supplies gas. T …
  • Moderna Therapeutics Inc:企業のM&A・事業提携・投資動向
    Moderna Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Moderna Therapeutics Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Toa Corp (1885):企業の財務・戦略的SWOT分析
    Toa Corp (1885) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Teleflex Incorporated:戦略・SWOT・企業財務分析
    Teleflex Incorporated - Strategy, SWOT and Corporate Finance Report Summary Teleflex Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Kangwon Land Inc.:企業の戦略・SWOT・財務情報
    Kangwon Land Inc. - Strategy, SWOT and Corporate Finance Report Summary Kangwon Land Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • EA Pharma Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary EA Pharma Co Ltd (EA Pharma), formerly Ajinomoto Pharmaceuticals Co Ltd, a subsidiary of Eisai Co Ltd is a clinical research organization that develops, manufactures and sells pharmaceutical products. The organization develops pharmaceutical products based on amino acid-related technologies …
  • Econocom Group SA (ECONB):企業の財務・戦略的SWOT分析
    Econocom Group SA (ECONB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Ridley Corporation Ltd:企業の戦略・SWOT・財務分析
    Ridley Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Ridley Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • SAS Group:企業のM&A・事業提携・投資動向
    SAS Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SAS Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Dai Nippon Printing Co Ltd (7912):企業の財務・戦略的SWOT分析
    Dai Nippon Printing Co Ltd (7912) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Vaxart Inc-製薬・医療分野:企業M&A・提携分析
    Summary Vaxart Inc (Vaxart) focuses on the development of recombinant vaccines based on its proprietary oral vaccine delivery platform. The company is currently developing tablet vaccines for seasonal and pandemic influenza, norovirus, and Respiratory Syncytial Virus (RSV). Vaxart’s vaccine delivery …
  • Rexel S.A.:企業の戦略・SWOT・財務情報
    Rexel S.A. - Strategy, SWOT and Corporate Finance Report Summary Rexel S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • NII Holdings Inc (NIHD):企業の財務・戦略的SWOT分析
    Summary NII Holdings Inc (NII Holdings) is a mobile communication service provider that offers communication products and services. The company offers solutions such as 3G mobile broadband services, content downloads and messaging. It also provides digital cellular voice services, data services, and …
  • Assystem SA (ASY)-エネルギー分野:企業M&A・提携分析
    Summary Assystem S.A. (Assystem) is a provider of engineering and innovation consultancy services. Through coordinating with clients, the company designs and develops across the life cycle products and services. It offers various R&D services range from functional analysis to commissioning by design …
  • Specialty Fashion Group Ltd (SFH):企業の財務・戦略的SWOT分析
    Specialty Fashion Group Ltd (SFH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆